Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study

Heart

Volumn 90, Issue 8, 2004, Pages 859-865

  Souverein, P C ^a   Berard, A ^b   Van Staa, T P ^a,c   Cooper, C ^c   Egberts, A C G ^a   Leufkens, H G M ^a   Walker, B R ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MORBIDITY; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIDE EFFECT;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 3442876736     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.020180     Document Type: Article

References (29)

1. Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids in the United Kingdom. QJM 2000;93:105-11.
2. Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
3. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986;80:925-9.
4. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994;70:863-70.
5. Haynes RC Jr. Adrenocorticotropic hormone; adrenocorticol steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, et al, eds. Goodman and Gilman's The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:1431-62.
6. Ross EJ, Linch DC. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982;ii:646-9.
7. Watt GC, Harrap SB, Foy CJ, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach ta the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-82.
8. Filipovsky J, Ducimetiere P, Eschwege E, et al. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996;14:229-35.
9. Walker BR, Phillips DI, Noon JP, et al. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 1998;31:891-5.
10. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998;83:1853-9.
11. Phillips DI, Barker DJ, Fall CH, et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 1998;83:757-60.
12. Fraser R, Ingram MC, Anderson NH, et al. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999;33:1364-8.
13. Walker BR, Soderberg S, Lindahl B, et al. Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med 2000;247:198-204.
14. Reynolds RM, Walker BR, Syddall HE, et al. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001;86:245-50.
15. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
16. Rab ST, King SB 3rd, Roubin GS, et al. oronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 1991;18:1524-8.
17. Villa AE, Guzman LA, Chen W, et al. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994;93:1243-9.
18. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council low-dose glucocorticoid study group. N Engl J Med 1995;333:142-6.
19. Mutru O, Laakso M, Isomaki H, et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ (Clin Res Ed) 1985;290:1797-9.
20. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol 1997;24:415-6.
21. Wallberg-Jonsson S, Johansson H, Ohman ML, et al. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: a retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
22. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115-20.
23. DeMaria AN. Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 2002;89:33D-8D.
24. Walley T, Mantgani A. The UK general practice research database. Lancet 1997;350:1097-9.
25. Van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994;3:32-4.
26. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
27. Psaty BM, Koepsell TD, Lin D, et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999;47:749-54.
28. Colao A, Pivonello R, Spiezia S, et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999;84:2664-72.
29. Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003;88:2527-33.